Basic Information
NeuSpera Medical, Inc. is committed to developing implantable medical device technology to improve the lives of patients battling chronic illnesses. This platform technology is the first to be used as an anticipated indication for urgency urinary incontinence (UUI), with the ultimate goal of providing targeted bioelectronic medicine for a variety of conditions. The minimally invasive implant from NeuSpera, featuring an external wearable transmitter, offers the potential for treatments to reach deeper and more difficult-to-access anatomical locations within the body.
NeuSpera Medical, Inc.
California,United States of America
15~50 people
December 03, 2013
--

